FDG PET, Mucosal Melanoma
Conditions
Brief summary
This project will target patients with histopathologically diagnosed mucosal melanoma using \[¹⁸F\]FDG PET/CT imaging for retrospective prognostic evaluation.The primary objective is to explore the value of \[¹⁸F\]FDG PET/CT imaging in the prognostic assessment of mucosal melanoma, and to determine the correlations between quantitative \[¹⁸F\]FDG PET parameters and progression-free survival (PFS) as well as overall survival (OS), so as to provide reference evidence for individualized treatment decision-making.
Interventions
OTHERTelephone follow-up
Telephone follow-up
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients with histopathologically confirmed mucosal melanoma.
Exclusion criteria
1. Having another primary malignancy (other than mucosal melanoma). 2. Being lost to follow-up. 3. Being under 18 years of age. 4. Being pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | Up to 4 years | Overall survival (OS) is defined as the time elapsed from the date of the ¹⁸F-FDG PET/CT examination to the date of death. |
| Progression-free survival | Up to 4 years | Progression-free survival (PFS) is defined as the time from the date of \[18F\]FDG PET/CT imaging to the earliest date of disease progression, recurrence, or death. |
Countries
China
Outcome results
None listed